Characteristics | Gushen Antai Pill group (n = 186) | Placebo group (n = 185) | P value |
---|---|---|---|
Age at inclusion (years; mean (SD)) | 33.9 (4.5) | 34.3 (4.0) | 0.581 |
Age ≥ 37 | 45 (24.2) | 53 (28.6) | 0.330 |
Age ≥ 40 | 22 (11.8) | 18 (9.7) | 0.515 |
Body mass index (kg/m2; mean (SD)) ⁑ | 23.1 (3.4) | 23.5 (3.2) | 0.103 |
Duration of infertility (years; median (P25, P75)) | 3 (2, 5) | 3 (2, 5) | 0.604 |
Types of infertility | 0.882 | ||
Primary infertility | 73 (39.2) | 74 (40.0) | |
Secondary infertility | 113 (60.8) | 111 (60.0) | |
Primary cause of infertility: | 0.651 | ||
Tubal factor | 134 (72.0) | 122 (65.9) | |
Male factor | 26 (14.0) | 25 (13.5) | |
Tubal + Male factor | 8 (4.3) | 14 (7.6) | |
Unexplained infertility | 12 (6.5) | 16 (8.7) | |
Ovulation disturbance | 3 (1.6) | 2 (1.1) | |
Diminished ovarian reserve | 2 (1.1) | 3 (1.6) | |
Endometriosis | 1 (0.5) | 3 (1.6) | |
AMH (ng/ml; median (P25, P75)) | 2.0 (1.3, 3.0) | 2.2 (1.3, 3.0) | 0.558 |
Total AFC (median (P25, P75)) | 11 (8, 14) | 11 (9, 14) | 0.913 |
FSH (mIU/ml; median (P25, P75)) | 7.1 (6.0, 8.9) | 7.1 (5.9, 8.9) | 0.734 |
LH (mIU/ml; median (P25, P75)) | 4.5 (2.8, 6.1) | 4.5 (2.8, 6.5) | 0.806 |
Estradiol (pg/ml; median (P25, P75)) | 32.4 (25.0, 45.9) | 30.7 (24.6, 40.6) | 0.122 |